DFDA

Surgical Excision / Electrocautery / Laser Ablation

Treatment for Hpv Infection

Typical Dosage: Surgical removal of lesions

Effectiveness
95%
Safety Score
78%
Clinical Trials
2
Participants
7.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
78
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical removal of lesions
Time to Effect
Immediate clearance, 1-4 weeks healing
Treatment Duration
Single procedure, 1-4 weeks healing
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,700
Side Effect Mgmt:$150
Total Annual:$1,850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
Outcome-Based Costs
Cost per Responder
$1,947
Cost per Remission
$1,947
Comparison vs Cryotherapy
Cost Difference
+$800/year
More expensive
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Surgical Excision / Electrocautery / Laser Ablation Outcomes

for Hpv Infection

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Pain
+70%
Scarring
+40%
Infection
+10%
Bleeding
+7%
Dyspigmentation
+15%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Surgical Excision / Electrocautery / Laser Ablation in Hpv Infection

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

NCT02520986RECRUITINGNA
View Study
114 participants
INTERVENTIONAL
Herne, Germany
Started: Dec 1, 2016
Completed Clinical Trials
1 completed trial for Surgical Excision / Electrocautery / Laser Ablation in Hpv Infection

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

NCT02135419COMPLETEDPHASE3
View Study
4.45K participants
INTERVENTIONAL
Los Angeles, United States +24 more
Started: Sep 24, 2014